Beneficial effect of melatonin in the treatment of neonatal sepsis

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 31, Issue 17, 2018, Pages 2299-2303

  El Gendy, Fady M ^a   El Hawy, Mahmoud A ^a   Hassan, Mohamed G ^b  

^a MENOUFIA UNIVERSITY   (Egypt)

^b Benha Children's Hospital   (Egypt)

Author keywords

Melatonin; neonates; sepsis

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN; MELATONIN; ANTIINFECTIVE AGENT;

ADJUVANT THERAPY; ARTICLE; BLOOD CELL COUNT; CASE CONTROL STUDY; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL OUTCOME; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FOLLOW UP; FREE RADICAL SCAVENGING ASSAY; HUMAN; HUMAN CELL; MALE; NEWBORN; NEWBORN SEPSIS; OXIDATIVE STRESS; PHYSICAL EXAMINATION; PREMATURITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SENSITIVITY ANALYSIS; SINGLE DRUG DOSE; TREATMENT RESPONSE; CONTROLLED CLINICAL TRIAL; GESTATIONAL AGE; NEONATAL INTENSIVE CARE UNIT; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; CASE-CONTROL STUDIES; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INTENSIVE CARE UNITS, NEONATAL; MALE; MELATONIN; NEONATAL SEPSIS; TREATMENT OUTCOME;

EID: 85021866349     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.1080/14767058.2017.1342794     Document Type: Article

References (24)

1. Lawn JE, Cousens S, Zupan J., 4 Million neonatal deaths: when? where? why? Lancet. 2005;365(9462):891–900.
2. Gustot T., Multiple organ failure in sepsis: prognosis and role of systemic inflammatory response. Curr Opin Crit Care. 2011;17(2):153–159.
3. Mondal SK, Nag DR, Bandyopadhyay R, et al. Neonatal sepsis: Role of a battery of immunohematological tests in early diagnosis. Int J Appl Basic Med Res. 2012;2(1):43–47.
4. Angus DC, Wax RS., Epidemiology of sepsis: an update. Crit Care Med. 2001;29:S109–S116.
5. Bhandari V, Wang C, Rinder C, et al. Hematologic profile of sepsis in neonates: neutrophil CD64 as a diagnostic marker. Pediatrics. 2008;121(1):129–134.
6. Mochida S, Matsura T, Yamashita A, et al. Geranylgeranylacetone ameliorates inflammatory response to lipopolysaccharide (LPS) in murine macrophages: inhibition of LPS binding to the cell surface. J Clin Biochem Nutr. 2007;41(2):115–123.
7. Galley HF., Oxidative stress and mitochondrial dysfunction in sepsis. Br J Anaesth. 2011;107(1):57–64.
8. Liu J, Wu F, Liu Y, et al. The effect of melatonin on mitochondrial function in endotoxemia induced by lipopolysaccharide. Asian Australas J Anim Sci. 2011;24(6):857–866.
9. Locatelli F, Canaud B, Eckardt KU, et al. Oxidative stress in end-stage renal disease: an emerging threat to patient outcome. Nephrol Dial Transplant. 2003;18(7):1272–1280.
10. Mühl D, Woth G, Drenkovics L, et al. Comparison of oxidative stress & leukocyte activation in patients with severe sepsis & burn injury. Indian J Med Res. 2011;134:69–78.
11. Tan DX, Hardeland R, Manchester LC, et al. The changing biological roles of melatonin during evolution: from an antioxidant to signals of darkness, sexual selection and fitness. Biol Rev. 2010;85(3):607–623.
12. Rodríguez MI, Escames G, López LC, et al. Chronic melatonin treatment reduces the age-dependent inflammatory process in senescence-accelerated mice. J Pineal Res. 2007;42(3):272–279.
13. Hardeland R, Cardinali DP, Srinivasan V, et al. Melatonin–a pleiotropic, orchestrating regulator molecule. Prog Neurobiol. 2011;93(3):350–384.
14. Ballard JL, Khoury JC, Wedig K, et al. New Ballard Score, expanded to include extremely premature infants. J Pediatr. 1991;119(3):417–423.
15. Gitto E, Karbownik M, Reiter RJ, et al. Effects of melatonin treatment in septic newborns. Pediatr Res. 2001;50(6):756–760.
16. Stoll B, Weisman L., Infections in perinatology. Clin Perinatol. 2005;111:24.
17. Katz S., Neonatology: management, procedures, on-call problems, diseases, and drugs. Pediatr Emerg Care. 2011;27(2):162–163.
18. Chacko B, Sohi I., Early onset neonatal sepsis. Indian J Pediatr. 2005;72(1):23–26.
19. Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med. 2008;34(1):17–60.
20. Gitto E, Pellegrino S, Gitto P, et al. Oxidative stress of the newborn in the pre- and postnatal period and the clinical use of melatonin. J Pineal Res. 2009;46(2):128–139.
21. El Frargy M, El-Sharkawy HM, Attia GF., Use of melatonin as an adjuvant therapy in neonatal sepsis. J Neonat Perinat Med. 2015;8(3):227–232.
22. El-Mashad AR, Elmahdy H, El-Dib M, et al. Can melatonin be used as a marker for neonatal sepsis? J Matern Fetal Neonatal Med. 2016;29(17):2870–2873.
23. Marseglia L, D’Angelo G, Manti S, et al. Oxidative stress-mediated damage in newborns with necrotizing enterocolitis: a possible role of melatonin. Am J Perinatol. 2015;32(10):905–909.
24. Aversa S, Pellegrino S, Barberi I, et al. Potential utility of melatonin as an antioxidant during pregnancy and in the perinatal period. J Matern Fetal Neonatal Med. 2012;25(3):207–221.